CORE--CYCLOTRON/RADIOCHEMISTRY

$0P01FY2002HLNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 25888511 Paper 24962238 Paper 24503274 Paper 24043256 Paper 22939697 Paper 22897995 Paper 22770647 Paper 22582045 Paper 22320813 Paper 22033021 Paper 21907585 Paper 21818149 Paper 21516378 Paper 21441025 Paper 20457796 Paper 20233863 Paper 19949986 Paper 19808625 Paper 19647171 Paper 19610597 Paper 19380631 Paper 19356462 Paper 19326941 Paper 19323559 Paper 19306771 Paper 19300818 Paper 19217526 Paper 18984454 Paper 18836221 Paper 18632819 Paper 18513649 Paper 18056334 Paper 17998103 Paper 17585855 Paper 17556159 Paper 17404471 Paper 17315977 Paper 17309226 Paper 17045173 Paper 17045164 Paper 16912371 Paper 16891117 Paper 16750782 Paper 16595504 Paper 16513617 Paper 16455640 Paper 16253813 Paper 16243642 Paper 16171718 Paper 16054054 Paper 15750159 Paper 15618539 Paper 15585904 Paper 15130745 Paper 14704276 Paper 14604660 Paper 14595380 Paper 12881222 Paper 12767397 Paper 12652815 Paper 12552126 Paper 12511534 Paper 12505860 Paper 12425323 Paper 12411560 Paper 12106931 Paper 12088733 Paper 11823126 Paper 11801714 Paper 11781357 Paper 11518642 Paper 11395312 Paper 11202060

Abstract

This core has the goal of providing radionuclides and synthetic precursors for Project 1 and radiopharmaceuticals for Projects 2-4. To this end two cyclotrons are maintained and radiopharmaceuticals labeled with oxygen-15, carbon-11 and fluorine-18. Copper-60 will be produced for a subproject in Project 1. The Core carried out the appropriate quality control testing. The Core also carries out metabolite analysis for Project 3. Developmental work will be continued on 11C-ethyliodide preparation and on the development of analytical techniques related to Project 4.

View original record on NIH RePORTER →